{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:15Z","timestamp":1707524535524},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,30]]},"DOI":"10.7759\/cureus.21739","type":"journal-article","created":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T20:30:30Z","timestamp":1643574630000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis and Treatment Challenges of an Atypical Case of Pemphigus vulgaris During the COVID-19 Pandemic"],"prefix":"10.7759","author":[{"given":"M\u0103d\u0103lina Laura","family":"Banciu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Codruta","family":"Dobrica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria","family":"Malciu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"V\u00e2j\u00e2itu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vlad Mihai","family":"Voiculescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-018-8986-7","article-title":"Pemphigus group: overview, epidemiology, mortality, and comorbidities","volume":"66","author":"Kridin K","year":"2018","unstructured":"Kridin K. Pemphigus group: overview, epidemiology, mortality, and comorbidities. Immunol Res. 2018, 66:255-270. 10.1007\/s12026-018-8986-7","journal-title":"Immunol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-014-1531-1","article-title":"Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid","volume":"307","author":"Alpsoy E","year":"2015","unstructured":"Alpsoy E, Akman-Karakas A, Uzun S. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid. Arch Dermatol Res. 2015, 307:291-298. 10.1007\/s00403-014-1531-1","journal-title":"Arch Dermatol Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2011.01.013","article-title":"Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis)","volume":"29","author":"Joly P","year":"2011","unstructured":"Joly P, Litrowski N. Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis). Clin Dermatol. 2011, 29:432-436. 10.1016\/j.clindermatol.2011.01.013","journal-title":"Clin Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-200479","article-title":"Pemphigus vulgaris: a multidisciplinary approach to management","volume":"2013","author":"Vinall C","year":"2013","unstructured":"Vinall C, Stevens L, McArdle P. Pemphigus vulgaris: a multidisciplinary approach to management. BMJ Case Rep. 2013, 2013:10.1136\/bcr-2013-200479","journal-title":"BMJ Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.otc.2010.09.005","article-title":"Vesiculobullous eruptions of the oral cavity","volume":"44","author":"Said S","year":"2011","unstructured":"Said S, Golitz L. Vesiculobullous eruptions of the oral cavity. Otolaryngol Clin North Am. 2011, 44:133-160. 10.1016\/j.otc.2010.09.005","journal-title":"Otolaryngol Clin North Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz M","year":"2017","unstructured":"Kasperkiewicz M, Ellebrecht CT, Takahashi H, Yamagami J, Zillikens D, Payne AS, Amagai M. Pemphigus. Nat Rev Dis Primers. 2017, 3:17026. 10.1038\/nrdp.2017.26","journal-title":"Nat Rev Dis Primers"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01418","article-title":"Pemphigus: current and future therapeutic strategies","volume":"10","author":"Didona D","year":"2019","unstructured":"Didona D, Maglie R, Eming R, Hertl M. Pemphigus: current and future therapeutic strategies. Front Immunol. 2019, 10:1418. 10.3389\/fimmu.2019.01418","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00218","article-title":"The evolving story of autoantibodies in pemphigus vulgaris: development of the \"super compensation hypothesis\"","volume":"5","author":"Sinha AA","year":"2018","unstructured":"Sinha AA, Sajda T. The evolving story of autoantibodies in pemphigus vulgaris: development of the \"super compensation hypothesis\". Front Med (Lausanne). 2018, 5:218. 10.3389\/fmed.2018.00218","journal-title":"Front Med (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04608","article-title":"The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris","volume":"146","author":"Harman KE","year":"2002","unstructured":"Harman KE, Gratian MJ, Shirlaw PJ, Bhogal BS, Challacombe SJ, Black MM. The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris. Br J Dermatol. 2002, 146:684-687. 10.1046\/j.1365-2133.2002.04608","journal-title":"Br J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2006.47.2.278","article-title":"Transition from pemphigus foliaceus to pemphigus vulgaris: case report with literature review","volume":"47","author":"Park SG","year":"2006","unstructured":"Park SG, Chang JY, Cho YH, Kim SC, Lee MG. Transition from pemphigus foliaceus to pemphigus vulgaris: case report with literature review. Yonsei Med J. 2006, 47:278-281. 10.3349\/ymj.2006.47.2.278","journal-title":"Yonsei Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16752","article-title":"Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)","volume":"34","author":"Joly P","year":"2020","unstructured":"Joly P, Horvath B, Patsatsi \u0391, et al.. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV). J Eur Acad Dermatol Venereol. 2020, 34:1900-1913. 10.1111\/jdv.16752","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01540.x","article-title":"The role of IVIg treatment in severe pemphigus vulgaris","volume":"20","author":"Baum S","year":"2006","unstructured":"Baum S, Scope A, Barzilai A, Azizi E, Trau H. The role of IVIg treatment in severe pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2006, 20:548-552. 10.1111\/j.1468-3083.2006.01540.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.160509","article-title":"Therapeutic plasma exchange - a new dawn in the treatment of pemphigus vulgaris","volume":"60","author":"Kumar R","year":"2015","unstructured":"Kumar R, Jindal A, Kaur A, Gupta S. Therapeutic plasma exchange - a new dawn in the treatment of pemphigus vulgaris. Indian J Dermatol. 2015, 60:419. 10.4103\/0019-5154.160509","journal-title":"Indian J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/v11080762","article-title":"Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms","volume":"11","author":"Smatti MK","year":"2019","unstructured":"Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019, 11:762. 10.3390\/v11080762","journal-title":"Viruses"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-021-00971-8","article-title":"Pemphigus vulgaris after COVID-19: a case of induced autoimmunity","volume":"3","author":"De Medeiros VL","year":"2021","unstructured":"De Medeiros VL, Monteiro-Neto AU, Fran\u00e7a DD, Castelo Branco R, de Miranda Coelho \u00c9O, Takano DM. Pemphigus vulgaris after COVID-19: a case of induced autoimmunity. SN Compr Clin Med. 2021, 3:1768-1772. 10.1007\/s42399-021-00971-8","journal-title":"SN Compr Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/21868.9717","article-title":"Rituximab: a magic bullet for pemphigus","volume":"11","author":"Anandan V","year":"2017","unstructured":"Anandan V, Jameela WA, Sowmiya R, Kumar MM, Lavanya P. Rituximab: a magic bullet for pemphigus. J Clin Diagn Res. 2017, 11:WC01-WC06. 10.7860\/JCDR\/2017\/21868.9717","journal-title":"J Clin Diagn Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-020-00448-8","article-title":"Type I allergic reaction to rituximab upon first lifetime exposure: a case report","volume":"16","author":"Polito V","year":"2020","unstructured":"Polito V, Barbacki A, Isabwe G. Type I allergic reaction to rituximab upon first lifetime exposure: a case report. Allergy Asthma Clin Immunol. 2020, 16:56. 10.1186\/s13223-020-00448-8","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2165\/11310740-000000000-00000","article-title":"Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data","volume":"10","author":"G\u00fcrcan HM","year":"2009","unstructured":"G\u00fcrcan HM, Ahmed AR. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data. Am J Clin Dermatol. 2009, 10:383-396. 10.2165\/11310740-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2021.01.020","article-title":"Drug repurposing of dermatologic medications to treat coronavirus disease 2019: science or fiction?","volume":"39","author":"Vassileva S","year":"2021","unstructured":"Vassileva S, Mateeva V, Drenovska K. Drug repurposing of dermatologic medications to treat coronavirus disease 2019: science or fiction?. Clin Dermatol. 2021, 39:430-445. 10.1016\/j.clindermatol.2021.01.020","journal-title":"Clin Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/82142-diagnosis-and-treatment-challenges-of-an-atypical-case-of-pemphigus-vulgaris-during-the-covid-19-pandemic","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:04Z","timestamp":1707507424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/82142-diagnosis-and-treatment-challenges-of-an-atypical-case-of-pemphigus-vulgaris-during-the-covid-19-pandemic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,30]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.21739","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,30]]}}}